Global Med Technologies(R) Welcomes Pennsylvania Hospital Group as New Client
December 15 2009 - 9:00AM
PR Newswire (US)
Jameson Health System Chooses SafeTrace Tx(R) Transfusion Solution
- Northeast Client Base now numbers over 125 sites - DENVER, Dec.
15 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc.
("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) ,
an international healthcare information technology company, today
announced that its Wyndgate Technologies® division has licensed its
SafeTrace Tx® transfusion management software to Jameson Health
System ("Jameson") of New Castle, Pennsylvania. Jameson will also
be using the services of PeopleMed®, Inc. for validation and
Hemo-Net® for remote hosting. Terms of the agreement were not
disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global
Med's SafeTrace Tx is a leading transfusion management software
solution for transfusion services and hospital blood banks. It will
provide Jameson with comprehensive tracking of orders, specimens,
blood products, derivatives, and accessories, with a complete
testing and transfusion history in one consolidated record.
SafeTrace Tx will help guide blood bank technicians in selecting,
crossmatching and issuing appropriate blood products for their
patients as well as helping to reduce waste and increase
efficiency. SafeTrace Tx has patented features which also allow
hospitals to effectively share patient data and work more
efficiently within a multi-facility system. Wm. Scott Dustin,
Global Med's Senior Vice President of Sales and Marketing, the
Americas, commented, "Global Med has been an industry leader in the
blood banking industry for over a decade. The Company now provides
comprehensive business solutions for our clients. We are pleased to
be able to assist Jameson Health System with a robust transfusion
management system and additional services to get them operational
quickly. Global Med's newly acquired Hemo-Net division will provide
cost-saving remote hosting for their software, while our PeopleMed
subsidiary will assist Jameson's staff with the system validation
for a more rapid implementation." About Jameson Health System
Jameson Health System operates two campuses, Jameson North and
Jameson South, a 308 bed facility. Jameson is committed to
providing convenient, affordable, high quality healthcare to the
community. The organization has primary care services, three
community health centers, acute inpatient and outpatient services
and post acute care services. Jameson Hospital, the primary
subsidiary of Jameson Health System, Inc., continues to be a
healthcare leader and the largest employer in Lawrence County,
Pennsylvania. About Global Med Technologies®, Inc. Global Med
Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated
products and services for the healthcare industry. As a leading
provider of blood and laboratory systems and services, Global Med's
products are deployed in 20 countries and serve over 2,100
transfusion centers, blood banks and laboratory sites. Global Med's
domestic companies are Wyndgate Technologies®, a leader in software
products and services for donor centers and hospital transfusion
services; eDonor®, which offers web-based donor relationship
management systems; Hemo-Net®, a healthcare application service
provider; and PeopleMed®, Inc., which implements cost-effective
software validation, consulting and compliance solutions to
hospitals and donor centers. Global Med's European subsidiary,
Inlog, SA, is a leading developer of donor center and transfusion
management systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. For more information about Global Med's products
and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I.
Ruxin, M.D. of Global Med Technologies, Inc., +1-303-238-2000 Web
Site: http://www.globalmedtech.com/
Copyright